NACDS Urges Standardized Pharmacy Performance Measures, DIR Fee Reform in Statement to Key House Committee As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care

2021-05-04T16:25:45-04:00Categories: Press Release|Tags: , , , , |

As the House Committee on Energy and Commerce’s Health Subcommittee pursues drug-pricing reform, NACDS also pledges to work with Congress for policies that would not further undermine or complicate pharmacy reimbursement in the Part D program nor potentially harm patients’ access to affordable care

Senate Finance Committee Wages Bipartisan Effort Across Branches of Government to Relieve Patients and Pharmacies from Pharmacy DIR Fees Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues

2019-09-12T13:01:36-04:00Categories: Press Release|Tags: , , , |

Pharmacy welcomes letter from over 80 percent of Committee members to Trump Administration, urging closure of Medicare regulatory loophole as legislative push continues

Pharmacy Urges Decisive Action to Close DIR Fee Loophole, Appreciates Senate Finance Committee’s Initial Bipartisan Movement on Issue “DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

2019-07-25T17:02:08-04:00Categories: Press Release|Tags: , , , |

“DIR relief means closing the loophole that is over-charging seniors and Medicare and making it unsustainable for pharmacies. DIR relief is essential for any drug-pricing legislation”

105 U.S. Reps., 28 U.S. Senators Urge Trump Administration to Fix Pharmacy DIR Fees Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies

2019-06-20T10:17:10-04:00Categories: Press Release|Tags: , , , |

Pharmacy groups unite to laud bipartisan Congressional focus on closing the loophole that inflates drug costs for patients and Medicare, and jeopardizes pharmacies.

Go to Top